(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Corvus Pharmaceuticals is 108420
| Date | Daily Closing Price | Open | High | Low | Volume |
| 30 Tue Apr 2024 | 1.55 | 1.60 | 1.60 | 1.53 | 0.521 times |
| 29 Mon Apr 2024 | 1.58 | 1.48 | 1.61 | 1.44 | 1.217 times |
| 26 Fri Apr 2024 | 1.45 | 1.56 | 1.62 | 1.44 | 1.147 times |
| 25 Thu Apr 2024 | 1.48 | 1.47 | 1.52 | 1.41 | 0.611 times |
| 24 Wed Apr 2024 | 1.51 | 1.60 | 1.60 | 1.49 | 0.835 times |
| 23 Tue Apr 2024 | 1.53 | 1.43 | 1.57 | 1.43 | 1.266 times |
| 22 Mon Apr 2024 | 1.44 | 1.39 | 1.50 | 1.39 | 1.205 times |
| 19 Fri Apr 2024 | 1.40 | 1.40 | 1.44 | 1.36 | 0.542 times |
| 18 Thu Apr 2024 | 1.41 | 1.38 | 1.45 | 1.30 | 1.295 times |
| 17 Wed Apr 2024 | 1.36 | 1.50 | 1.51 | 1.36 | 1.038 times |
My analysis of stock is bullish for shortterm, and stock might move up till 1.7 or till 1.8. Use a stoploss of 1.54 and if this stock hits its stoploss, then it can fall down till 1.43
Share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Target | 1.30 |
| Downside Target | 1.39 |
| Downside Target | 1.42 |
| Downside Target | 1.54 |
| Upside Target | 1.61 |
| Upside Target | 1.71 |
| Upside Target | 1.79 |
| Upside Target | 1.92 |
| Upside Target | 1.94 |
| Upside Target | 2.34 |
| Upside Target | 2.42 |
| Upside Target | 2.58 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Intraday Target | 1.46 |
| Downside Intraday Target | 1.36 |
| Upside Intraday Target | 1.63 |
| Upside Intraday Target | 1.7 |
| Downside Intraday Target | 1.53 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 30 Tue Apr 2024 | 1.55 | 1.48 | 1.61 | 1.44 | 0.343 times |
| 26 Fri Apr 2024 | 1.45 | 1.39 | 1.62 | 1.39 | 1.162 times |
| 19 Fri Apr 2024 | 1.40 | 1.53 | 1.54 | 1.30 | 0.572 times |
| 12 Fri Apr 2024 | 1.53 | 1.75 | 1.79 | 1.46 | 0.73 times |
| 05 Fri Apr 2024 | 1.75 | 1.78 | 1.94 | 1.63 | 1.114 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 30 Tue Apr 2024 | 1.55 | 1.78 | 1.94 | 1.30 | 0.663 times |
| 28 Thu Mar 2024 | 1.78 | 2.25 | 2.34 | 1.71 | 1.061 times |
| 29 Thu Feb 2024 | 2.24 | 2.00 | 2.58 | 1.94 | 1.036 times |
| 31 Wed Jan 2024 | 2.00 | 1.73 | 2.42 | 1.65 | 0.905 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Corvus Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.47 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Corvus Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.47 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.